©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1332-1341
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1332
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1332
Table 5 Treatment and outcomes of patients with metastatic breast cancer to the upper gastrointestinal tract
| Esophagus (%) | Stomach (%) | |
| Treatment of primary tumor | ||
| Surgery | 65 (97) | 70 (80) |
| Radiotherapy | 33 (49) | 28 (32) |
| Hormonal therapy | 13 (19) | 33 (38) |
| Chemotherapy | 20 (30) | 42 (48) |
| Treatment of metastases | ||
| Surgery | 20 (30) | 12 (11) |
| Surgery and chemotherapy/hormonal therapy | 13 (20) | 15 (15) |
| Chemotherapy/hormonal therapy | 15 (23) | 74 (70) |
| Radiotherapy only | 6 (9) | 3 (3) |
| Radiation and chemotherapy/hormonal therapy | 10 (15) | - |
| Dilation | 32 (48) | - |
| Stent placement | 9 (14) | - |
| Outcome | ||
| Alive at one month | 7 (13) | - |
| Alive at one year | 19 (35) | 13 (24) |
| Dead at 1 yr | 24 (44) | 20 (37) |
| Dead at 2 yr | - | 18 (33) |
| Dead at 5 yr | 9 (16) | - |
| Dead at 10 yr | - | 1 (2) |
- Citation: Da Cunha T, Restrepo D, Abi-Saleh S, Dharan M. Breast cancer metastasizing to the upper gastrointestinal tract (the esophagus and the stomach): A comprehensive review of the literature. World J Gastrointest Oncol 2023; 15(8): 1332-1341
- URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1332.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1332